C. Garrett Rappazzo - Concepedia

Concepedia

Author

C. Garrett Rappazzo

Adimab (United States)ORCID

Also Known As

C Garrett Rappazzo, C. G. Rappazzo, C. Garrett Rappazzo, Gralinski, Lisa E.

31

Publications

1.2K

Citations

14

H-Index

16

Concepts

All Affiliations

Adimab (United States)The University of Texas at Austin The Geneva Foundation Massachusetts Institute of Technology United States Army Medical Research Institute of Infectious Diseases

CG

About

C. Garrett Rappazzo is an author at Adimab (United States) specializing in vaccination, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	180
2	Immunology	3	3	180
3	Immunotherapy	2	2	156
4	Autoimmunity	1	1	24
5	Immunodominance	1	1	24

C. Garrett Rappazzo

×

14

Publications

1.2K

Citations

14

H-Index

	Year	Citations
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody C. Garrett Rappazzo, Longping V. Tse, Chengzi I. Kaku, Science	2021	382
Prolonged evolution of the human B cell response to SARS-CoV-2 infection Mrunal Sakharkar, C. Garrett Rappazzo, Wendy Wieland‐Alter, Science Immunology	2021	199
Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice C. Garrett Rappazzo, Hannah C. Watkins, Cassandra Guarino, Vaccine VaccinationMucosal VaccinationCross-protectionVaccine DevelopmentImmunology	2016	136
Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection Hannah C. Watkins, C. Garrett Rappazzo, Jaclyn S. Higgins, Molecular Therapy	2017	102
IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development Amy Li, Rebecca H. Herbst, David Canner, Cell Reports	2019	78
Repertoire-scale determination of class II MHC peptide binding via yeast display improves antigen prediction C. Garrett Rappazzo, Brooke D. Huisman, Michael E. Birnbaum Nature Communications	2020	65
A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants Denise Haslwanter, M. Eugenia Dieterle, Anna Z. Wec, mBio	2021	59
Potently neutralizing and protective anti-human metapneumovirus antibodies target diverse sites on the fusion glycoprotein C. Garrett Rappazzo, Ching‐Lin Hsieh, Scott A. Rush, Immunity	2022	34
Vaccination reshapes the virus-specific T cell repertoire in unexposed adults Yi‐Gen Pan, Benjamas Aiamkitsumrit, Laurent Bartolo, Immunity VaccinationVaccine DevelopmentAdaptive Immune SystemVaccine TargetImmunology	2021	24
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19 C. Garrett Rappazzo, Longping V. Tse, Chengzi I. Kaku, ImmunologyViral PathogenesisViral Structural ProteinImmunotherapySynthetic Immunology	2020	20

Page 1